MAZZEO, SALVATORE
 Distribuzione geografica
Continente #
NA - Nord America 1.203
EU - Europa 1.069
AS - Asia 295
AF - Africa 2
SA - Sud America 2
Totale 2.571
Nazione #
US - Stati Uniti d'America 1.197
RU - Federazione Russa 645
IT - Italia 139
IE - Irlanda 108
SE - Svezia 99
SG - Singapore 98
CN - Cina 65
HK - Hong Kong 65
DE - Germania 31
JO - Giordania 30
IN - India 25
GB - Regno Unito 12
FI - Finlandia 10
KR - Corea 10
CH - Svizzera 6
CA - Canada 5
ES - Italia 4
BE - Belgio 2
BR - Brasile 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
FR - Francia 2
BG - Bulgaria 1
GR - Grecia 1
IL - Israele 1
JP - Giappone 1
MK - Macedonia 1
NL - Olanda 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
UA - Ucraina 1
Totale 2.571
Città #
Santa Clara 357
Chandler 133
Dublin 108
Fairfield 85
Singapore 77
Ashburn 67
Seattle 53
Moscow 45
Hong Kong 44
Woodbridge 39
Houston 37
Altamura 31
Lawrence 30
Cambridge 28
Florence 27
Wilmington 26
Bremen 25
Mumbai 19
Shanghai 19
Dallas 18
Buffalo 16
Princeton 16
New York 12
Kent 10
Boston 9
Medford 9
Beijing 8
Helsinki 8
Los Angeles 8
Ann Arbor 7
Seoul 7
San Diego 6
West Jordan 6
Yubileyny 6
Dearborn 5
Pune 5
Toronto 5
Boardman 4
London 4
Zurich 4
Como 3
Duncan 3
Kunming 3
Milan 3
Palermo 3
Abidjan 2
Arezzo 2
Bern 2
Brussels 2
Catania 2
Colle di Val d'Elsa 2
Copenhagen 2
Falls Church 2
Genoa 2
Hillsboro 2
Lappeenranta 2
Manchester 2
Monza 2
Naples 2
Norwalk 2
Pisa 2
Poggibonsi 2
Sant'Agata di Militello 2
Suwon 2
Turin 2
Andover 1
Athens 1
Bagno A Ripoli 1
Barcelona 1
Bitola 1
Bologna 1
Bolzano 1
Brentford 1
Böblingen 1
Campi Bisenzio 1
Chennai 1
Fiesole 1
Fontebuona 1
Fuzhou 1
Grottaferrata 1
Guangzhou 1
Harbin 1
Hebei 1
Hounslow 1
Kilburn 1
Kumamoto 1
Lisbon 1
Lucca 1
Madrid 1
Nanchang 1
Nantong 1
Napoli 1
Osimo 1
Panama City 1
Pinerolo 1
Prague 1
Prescot 1
Redwood City 1
Rio de Janeiro 1
Rome 1
Totale 1.513
Nome #
Acute Symptomatic Sinus Bradycardia in High-Dose Methylprednisolone Therapy in a Woman With Inflammatory Myelitis: A Case Report and Review of the Literature 134
The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study 133
From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study 126
KIBRA T allele influences memory performance and progression of cognitive decline: a 7-year follow-up study in subjective cognitive decline and mild cognitive impairment 118
The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study 110
Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer’s disease: an 11-year follow-up study 109
Early functional MRI changes in a prodromal semantic variant of primary progressive aphasia: a longitudinal case report 92
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 87
Cerebrospinal fluid biomarkers for dementia: A case of post-lumbar puncture epidural hematoma 85
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 82
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 81
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients 81
Per2 C111G polymorphism influences cognition in Subjective Cognitive Decline and Mild Cognitive Impairment. A 10-year follow-up study 78
A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet 78
Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements 78
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study 68
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 66
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 66
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 64
null 63
The effect of cag repeats within the non-pathological range in the htt gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment 62
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 61
Gender differences in cognitive reserve: implication for subjective cognitive decline in women 60
Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer's Disease 57
Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease 53
Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia 52
Intermediate alleles of HTT: A new pathway in longevity 51
Depressive Symptoms Moderate the Association Between Functional Level at Admission to Intensive Post-Stroke Rehabilitation and Effectiveness of the Intervention 44
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer’s Disease With machine learning: the PREVIEW study protocol 43
Heterogeneity and overlap in the continuum of linguistic profile of logopenic and semantic variants of primary progressive aphasia: a Profile Analysis based on Multidimensional Scaling study 39
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study 38
Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns 38
Comparing two picture naming tasks in primary progressive aphasia: Insights from behavioural and neural results 37
Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer’s Disease continuum? 36
Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment 36
The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment 33
Personalized modeling of Alzheimer's disease progression estimates neurodegeneration severity from EEG recordings 32
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 15
A case of hemichorea/hemiballismus in a patient with Alzheimer’s disease and history of Sydenham’s chorea: the return of an old acquaintance? 12
Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia 12
Totale 2.610
Categoria #
all - tutte 11.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.521


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020159 0 0 0 0 28 26 27 21 20 17 12 8
2020/2021118 11 6 2 20 9 5 4 9 24 8 12 8
2021/2022105 4 0 6 3 2 8 0 13 7 10 19 33
2022/2023587 58 117 42 44 40 92 69 28 80 2 11 4
2023/2024331 5 25 28 12 26 38 26 73 11 42 25 20
2024/20251.247 73 223 132 379 440 0 0 0 0 0 0 0
Totale 2.610